COPD

The FDA today approved a new treatment for chronic obstructive pulmonary disease: tiotropium bromide and olodaterol inhalation spray.

Pharmacists need to remain cognizant of COPD and asthma patient preferences to maintain adherence.

Clinical guidelines and government agencies are increasingly encouraging clinicians to consider patients' treatment preferences when chronic disease is present.

Link found between new onset obstructive sleep apnea and habitual sleepiness.

Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about what the teach-back method is and the pharmacist's role in patient counseling.

The FDA today expanded the indication of fluticasone furoate/vilanterol (Breo Ellipta) for the treatment of asthma.

Difficulty with several aspects of nebulizer use creates treatment hurdles for patients.

COPD patients must clear major hurdles before and after initiating nebulizer use.

Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, details some factors that contribute to nonadherence among patients with COPD.

Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about the importance of individualizing treatment for COPD.

Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about the burden COPD places on society.

Chronic obstructive pulmonary disease Is preventable and treatable, especially if diagnosed early.

Chronic obstructive pulmonary disease Is preventable and treatable, especially if diagnosed early.

Well-trained pharmacists can successfully screen patients for COPD in the community setting.

Well-trained pharmacists can successfully screen patients for COPD in the community setting.

Hospital readmissions are a major driver of spending in the Medicare program.

Several new treatments for COPD are in development.

Effective management of COPD can improve quality of life for patients and help reduce rehospitalizations.

From optimizing inhaler technique in patients with chronic obstructive pulmonary disease, to catching red flags when dispensing controlled substances to patients with chronic pain, pharmacists can improve patient outcomes in an evolving treatment landscape.

Leonard Nimoy's recent death from end-stage chronic obstructive pulmonary disease (COPD) brought the condition into the spotlight, and may bring patients with questions to the pharmacy counter.

With the wide selection of available inhalers, this article sheds light on factors that can influence COPD treatment success.

Most people hear "hospice" and think "cancer," but many end-stage chronic obstructive pulmonary disease patients also receive hospice care when their caregivers can no longer provide the medical attention they need.

A new start-up is looking to integrate smart sensors into current inhalers to increase adherence.

A healthy diet associated with reduced heart disease risk may also lower the risk of chronic obstructive pulmonary disease.

Symptoms include airflow obstruction, bronchial hyperresponsiveness, and airway inflammation.

See a new technique to treat severe asthma.

An examination of the pathophysiology of asthma.

Phase 3 registrational studies of TD-4208 are anticipated to begin in 2015

A review of the pathology of asthma and COPD, including the role of the immune system, along with the mechanisms behind the hypercapnia and hypoxemia of COPD, and the blue bloater vs. pink puffer pseudodichotomy.